SOD1 and malignant colon neoplasm: The substantial impact of K71Q mutant shown above suggests a possibility that the abundance of SOD1 acetylation may be a determinant of the sensitivity to the CPT-based chemotherapies, which are used in the clinical therapy of various types of human cancers including the first line treatment for colon cancer.